AU Stock MarketDetailed Quotes

ILAO Island Pharmaceuticals Ltd

Watchlist
  • 0.140
  • +0.050+55.56%
20min DelayNot Open Nov 27 14:37 AET
21.83MMarket Cap0.00P/E (Static)

Island Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
11,211.12%1.25M
11.07K
Operating revenue
11,211.12%1.25M
--11.07K
----
----
Cost of revenue
Gross profit
11,211.12%1.25M
11.07K
Operating expense
41.86%4.13M
3.53%2.91M
31.33%2.81M
2.14M
Selling and administrative expenses
-10.23%1.44M
0.34%1.6M
-15.90%1.6M
--1.9M
-General and administrative expense
-10.23%1.44M
0.34%1.6M
-15.90%1.6M
--1.9M
Research and development costs
99.24%2.27M
10.77%1.14M
39,690.42%1.03M
--2.59K
Other operating expenses
153.22%412.18K
-9.57%162.77K
-23.30%180K
--234.7K
Operating profit
0.80%-2.87M
-3.13%-2.9M
-31.33%-2.81M
-2.14M
Net non-operating interest income (expenses)
-360.97%-41.49K
-9K
Non-operating interest income
--4.71K
----
----
----
Non-operating interest expense
413.34%46.2K
--9K
----
----
Other net income (expenses)
-32.62%50.95K
-62.59%75.62K
1,558.34%202.12K
12.19K
Other non-operating income (expenses)
-32.62%50.95K
-62.59%75.62K
1,558.34%202.12K
--12.19K
Income before tax
-1.20%-2.86M
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Income tax
0
0
0
0
Earnings from equity interest net of tax
Net income
-1.20%-2.86M
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Net income continuous operations
-1.20%-2.86M
-8.58%-2.83M
-22.58%-2.61M
---2.13M
Noncontrolling interests
Net income attributable to the company
-1.20%-2.86M
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-1.20%-2.86M
-8.58%-2.83M
-22.58%-2.61M
-2.13M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue 11,211.12%1.25M11.07K
Operating revenue 11,211.12%1.25M--11.07K--------
Cost of revenue
Gross profit 11,211.12%1.25M11.07K
Operating expense 41.86%4.13M3.53%2.91M31.33%2.81M2.14M
Selling and administrative expenses -10.23%1.44M0.34%1.6M-15.90%1.6M--1.9M
-General and administrative expense -10.23%1.44M0.34%1.6M-15.90%1.6M--1.9M
Research and development costs 99.24%2.27M10.77%1.14M39,690.42%1.03M--2.59K
Other operating expenses 153.22%412.18K-9.57%162.77K-23.30%180K--234.7K
Operating profit 0.80%-2.87M-3.13%-2.9M-31.33%-2.81M-2.14M
Net non-operating interest income (expenses) -360.97%-41.49K-9K
Non-operating interest income --4.71K------------
Non-operating interest expense 413.34%46.2K--9K--------
Other net income (expenses) -32.62%50.95K-62.59%75.62K1,558.34%202.12K12.19K
Other non-operating income (expenses) -32.62%50.95K-62.59%75.62K1,558.34%202.12K--12.19K
Income before tax -1.20%-2.86M-8.58%-2.83M-22.58%-2.61M-2.13M
Income tax 0000
Earnings from equity interest net of tax
Net income -1.20%-2.86M-8.58%-2.83M-22.58%-2.61M-2.13M
Net income continuous operations -1.20%-2.86M-8.58%-2.83M-22.58%-2.61M---2.13M
Noncontrolling interests
Net income attributable to the company -1.20%-2.86M-8.58%-2.83M-22.58%-2.61M-2.13M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -1.20%-2.86M-8.58%-2.83M-22.58%-2.61M-2.13M
Diluted earnings per share
Basic earnings per share
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data